retatrutide eli lilly phase 2 results ESC 2024: improves lipid and cardiovascular risk profile in II trial Eli Lillys retatrutide what is

This approach helps to minimize the risk of side effects such as gastrointestinal (GI) problems

According to phase 2 clinical trials, retatrutide has the potential to improve cardiometabolic health, reduce cholesterol, triglyceride, and LDL, and promote fat breakdown

Injectable semaglutide, marketed as Ozempic, is approved for the management of type 2 diabetes

Retatrutide and Joint Pain: Evidence, Risks, and UK Guidance Retatrutide and joint pain is an emerging area of interest as this investigational triple receptor agonist progresses through clinical trials

It pulls from both fat stores and muscle tissue

For a full month, I was on the lowest dose